Skip to main content

Anne W. Beaven

Anne Beaven, MD, is the director of the lymphoma program. Beaven’s research primarily focuses on therapies in patients with lymphoma.

MD
Director, Lymphoma Program; Associate Professor
UNC-Chapel Hill
Clinical Research
Division of Hematology

Meet Anne Beaven

Area of Interest

I specialize in the treatment of patients with all types of lymphoma, including B and T-cell non-Hodgkin lymphoma subtypes and Hodgkin lymphoma. Cutaneous (skin) lymphomas, such as mycosis fungoids and Sezary syndrome, are of special interest to me. I also co-lead with Edith Bowers, MD, in dermatology, a multidisciplinary cutaneous lymphoma clinic.

In addition to taking care of patients in clinic, I develop and manage clinical trials for patients with lymphoma. I am heavily involved in the development of the UNC Lineberger CAR-T therapy program. This is an exciting approach that uses a patient’s own immune system to help fight their lymphoma.

Awards and Honors

  • Alliance Lymphoma Leadership Committee member, 2016-present
  • Lymphoma Research Foundation’s Mantle Cell Consortium member, 2014-present
  • Howard Hughes Grant to fund summer research in Chemistry, Wesleyan University, 1992
  • ASH Advocacy Leadership Institute, Washington DC Participant, October 2014
  • Department of Medicine Faculty Development Academy in Clinical/Health Services Research, Duke University Fellow, 2011-2013
  • T Cell Lymphoma Consortium member, 2010-present
  • American Society of Clinical Oncology member, 2005-present
  • Fellow, Clinical Research Curriculum NIH K30 HL04127 (David Ransohoff, PI), UNC-Chapel Hill, 2005-2007
  • American Society of Hematology member, 2004-present
  • Fellowship in Hematology/Oncology NIH T32 HL007149 (Beverly Mitchell, PI), UNC-Chapel Hill, 2004-2006

Find publications on PubMed

Anne Beaven